Malignant Neoplasm Clinical Trial
Official title:
Music Video for AYA-Parent Communication and Resilience
Verified date | October 2023 |
Source | Children's Oncology Group |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized trial studies how well music therapy and parents' education work in improving communication, emotional distress, and recovery in adolescents/young adult patients undergoing treatment for high-risk cancer and their parents. Making a music therapy video may improve communication, emotional distress, and recovery in younger patients undergoing treatment for cancer. It is not yet known whether music therapy and counseling for parents is more effective than information handouts for parents in improving communication and emotional distress in patients undergoing treatment for cancer.
Status | Completed |
Enrollment | 124 |
Est. completion date | October 2, 2023 |
Est. primary completion date | August 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 11 Years to 24 Years |
Eligibility | Inclusion Criteria: - AYA has initial or relapsed cancer diagnosis and is actively on treatment and will continue to be on treatment long enough to complete the intervention and evaluation (4 to 6 weeks) - AYA meets at least 1 of 3 criteria indicating potentially high palliative care or end-of-life needs: - Any high-risk cancer (i.e., metastatic or stage IV) - Receiving moderate- to high-intensity chemotherapy during 3-5 consecutive days in an in- or out-patient setting - A diagnosis with an estimated 5-year event-free survival of < 50% - AYA is able to participate in sessions as evaluated by the Karnofsky/Lansky score of 50% or greater - One consistent parent is willing and available to participate in all parent and evaluation sessions - AYA is not married and has no children - AYA and parent are able to read, understand, and speak English Exclusion Criteria: - Cancers not usually occurring in childhood/adolescent or young adult populations, such as lung or prostate cancer - Cognitive impairments that would make it difficult for AYA/parents to participate in the intervention or complete questionnaires (determination in consultation with attending physician, oncologist, and, for adolescents below age 18, the parents) |
Country | Name | City | State |
---|---|---|---|
United States | Children's Healthcare of Atlanta - Egleston | Atlanta | Georgia |
United States | Children's Healthcare of Atlanta - Scottish Rite | Atlanta | Georgia |
United States | Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio |
United States | Cook Children's Medical Center | Fort Worth | Texas |
United States | Riley Hospital for Children | Indianapolis | Indiana |
United States | Children's Mercy Hospitals and Clinics | Kansas City | Missouri |
United States | Children's Hospitals and Clinics of Minnesota - Minneapolis | Minneapolis | Minnesota |
United States | University of Texas Health Science Center at San Antonio | San Antonio | Texas |
Lead Sponsor | Collaborator |
---|---|
Children's Oncology Group | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | AYA illness-related distress measured by the Mishel Uncertainty in Illness Scale and the McCorkle Symptom Distress scale | The MPLUS software will be used to perform latent variable analysis of covariance (ANCOVA) to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA defensive coping measured by the Jalowiec Coping Scale-Revised | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA spiritual perspective measured by the Reed Spiritual Perspective Scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA social integration measured by the Perceived Social Support-Family scale, the Perceived Social Support-Friends scale, and the Perceived Social Support-Health Care Providers | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA family environment measured by the Family Adaptability and Cohesion Scale II | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA family environment measured by the Parent-Adolescent Communication scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA family environment measured by the Family Strengths Scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA positive coping measured by the Jalowiec Coping Scale-Revised | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA hope-derived meaning measured by the Herth Hope Index | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA self-transcendence measured by the Reed Self-Transcendence scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | AYA resilience measured by the Nowotny Confidence subscale, the Haase Resilience in Illness Scale, and the Index of Well-Being | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | Parental distress measured by the Perceived Stress Scale, the Profile of Mood States-Short Form, and the Spielberger's State-Trait Anxiety Inventory-State Component | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | Parent family environment measured by the Family Adaptability and Cohesion Scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | Parent family environment measured by the Parent-Adolescent Communication scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | Parent family environment measured by the Family Strengths Scale | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | Parent family environment measured by the Perceived Social Support-Health Care Providers | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days | |
Primary | Parent quality of life measured by the Index of Well-being | The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. | Up to 90 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02243592 -
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
|
||
Completed |
NCT03445572 -
Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer
|
N/A | |
Active, not recruiting |
NCT02860039 -
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
|
Phase 2 | |
Completed |
NCT01946217 -
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
|
N/A | |
Completed |
NCT01635413 -
Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)
|
N/A | |
Completed |
NCT00026169 -
Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure
|
Phase 1 | |
Recruiting |
NCT04534075 -
Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial
|
Phase 3 | |
Active, not recruiting |
NCT01806129 -
Reproductive Health Program in Patients With Cancer
|
N/A | |
Recruiting |
NCT03915717 -
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
|
||
Recruiting |
NCT02280161 -
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
|
||
Recruiting |
NCT05520281 -
Short-term Psychodynamic Psychotherapy in Serious Physical Illness
|
N/A | |
Terminated |
NCT00532064 -
Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib Chemotherapy
|
||
Completed |
NCT04990882 -
FAPI PET/CT Prospective Interobserver Agreement
|
||
Completed |
NCT01896778 -
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
|
N/A | |
Recruiting |
NCT05770102 -
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
|
Phase 2/Phase 3 | |
Recruiting |
NCT06090266 -
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Recruiting |
NCT05886764 -
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
|
N/A | |
Completed |
NCT01432431 -
Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff
|
N/A | |
Completed |
NCT01506440 -
Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
|